Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Health Technologies (MHT) is a collaborative partner and supplier in the nutraceutical and functional food industries, specializing in the sourcing and distribution of science-based ingredients. The company focuses on providing high-quality, clinically-backed raw materials such as branded extracts, peptides, and specialty chemicals for use in dietary supplements and health products. MHT differentiates itself through a focus on supply chain transparency, quality control, and technical support for product formulation. Their portfolio targets key wellness categories including cognitive function, joint mobility, and metabolic support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Health Technologies.